HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ling Bi Selected Research

Radiotherapy

1/2021MiR-182-5p promotes the Metastasis and Epithelial-mesenchymal Transition in Non-small Cell Lung Cancer by Targeting EPAS1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ling Bi Research Topics

Disease

15Neoplasms (Cancer)
01/2024 - 01/2018
10Lung Neoplasms (Lung Cancer)
01/2024 - 11/2014
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 01/2018
3Neoplasm Metastasis (Metastasis)
01/2023 - 01/2021
3Adenocarcinoma of Lung
10/2022 - 01/2020
3Prostatic Neoplasms (Prostate Cancer)
06/2022 - 04/2020
1Thrombosis (Thrombus)
04/2024
1Stomach Neoplasms (Stomach Cancer)
03/2024
1Anemia
01/2024
1Dyspnea (Shortness of Breath)
01/2024
1Hemoptysis
01/2024
1Pain (Aches)
01/2024
1Peripheral Nervous System Diseases (PNS Diseases)
01/2024
1Malignant Pleural Effusion
06/2023
1Mesothelioma
06/2023
1Pleural Effusion (Pleural Effusions)
06/2023
1Carcinogenesis
10/2022
1Hypoxia (Hypoxemia)
01/2021
1Fatigue
01/2020
1Thrombocytopenia (Thrombopenia)
01/2020
1Diarrhea
01/2020
1Adenocarcinoma
01/2019
1Breast Neoplasms (Breast Cancer)
06/2017
1Lewis Lung Carcinoma
01/2016

Drug/Important Bio-Agent (IBA)

3DNA (Deoxyribonucleic Acid)IBA
06/2022 - 04/2020
3Proteins (Proteins, Gene)FDA Link
04/2020 - 01/2019
2Tyrosine Kinase InhibitorsIBA
01/2022 - 01/2019
2ErbB Receptors (EGF Receptor)IBA
01/2022 - 01/2019
2osimertinibIBA
01/2022 - 01/2022
2RNA (Ribonucleic Acid)IBA
09/2021 - 01/2020
2Messenger RNA (mRNA)IBA
01/2020 - 01/2019
2Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA
01/2016 - 11/2014
1HirudinsIBA
04/2024
1AnticoagulantsIBA
04/2024
1Brachyury protein (Brachyury)IBA
03/2024
1Sijunzi decoctionIBA
01/2024
1Hemoglobins (Hemoglobin)IBA
01/2024
1Cell-Free Nucleic AcidsIBA
10/2023
1Therapeutic UsesIBA
06/2023
1EmulsionsIBA
06/2023
1CopperIBA
01/2023
1phosphoserine aminotransferase (phosphoserine transaminase)IBA
10/2022
1EnzymesIBA
10/2022
1Erlotinib Hydrochloride (CP 358,774)FDA Link
10/2022
1Histones (Histone)IBA
06/2022
1ApigeninIBA
06/2022
1yiqi yangyinIBA
01/2022
1Volatile Fatty AcidsIBA
01/2022
1Biomarkers (Surrogate Marker)IBA
01/2022
1CateninsIBA
01/2022
1agrimol BIBA
09/2021
1bisbenzimide ethoxide trihydrochloride (Hoechst 33342)IBA
09/2021
1PyronineIBA
09/2021
1AstringentsIBA
09/2021
1MicroRNAs (MicroRNA)IBA
01/2021
1endothelial PAS domain-containing protein 1IBA
01/2021
1Transcription Factors (Transcription Factor)IBA
01/2021
1Indicators and Reagents (Reagents)IBA
01/2021
1Poly AIBA
10/2020
1Cyclin B1IBA
04/2020
1RNA Polymerase II (RNA Polymerase B)IBA
01/2020
1Histone ChaperonesIBA
01/2019
1Small Interfering RNA (siRNA)IBA
01/2019
1Aromatase InhibitorsIBA
06/2017
1Estrogen ReceptorsIBA
06/2017
1Paclitaxel (Taxol)FDA LinkGeneric
01/2016
1Saline SolutionIBA
01/2016
1enhanced green fluorescent proteinIBA
01/2016
1feijiIBA
01/2016
1ganoderic acid MeIBA
11/2014

Therapy/Procedure

6Therapeutics
01/2024 - 06/2017
5Chinese Traditional Medicine (Traditional Chinese Medicine)
04/2024 - 01/2018
3Drug Therapy (Chemotherapy)
01/2021 - 01/2018
2Oral Administration
09/2021 - 04/2020
1Immunotherapy
01/2024
1Radiotherapy
01/2021
1Adjuvant Chemotherapy
01/2020
1Maintenance Chemotherapy
01/2018
1Chemoprevention
01/2018